newsfilter
← Latest News
GlobeNewswire·

Hemab Therapeutics Announces Closing of Upsized Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares

CAMBRIDGE, Mass. and COPENHAGEN, Denmark, May 04, 2026 (GLOBE NEWSWIRE) -- Hemab Therapeutics Holdings, Inc. (NASDAQ:COAG), a clinical-stage biotechnology company developing therapies that reimagine the treatment of